Biofourmis, a startup developing digital therapeutics and artificial intelligence to remotely monitor patients, said its valuation hit $1.3 billion after raising a $300 million Series D funding round led by General Atlantic. The Boston-based company said CVS Health joined the round, along with existing investors, and also announced Omar Ishrak, chairperson of Intel and former CEO of Medtronic, will chair its board. Biofourmis had previously raised a $100 million round in September 2020 led by SoftBank Investment Advisers at an undisclosed valuation. This Series D round brings the company's total funding to $445 million. Originally based in Singapore, Biofourmis moved its headquarters to the United States in 2019.

The probe into the death of actor Sushant Singh Rajput seemingly took a diversion when a drug angle came to light. However, a new report doing the rounds has a friend of the late actor denying claims that Rajput was consuming drugs. In an interview on Republic TV, Denmark-based man claiming to be a friend of the actor, revealed that he met Sushant at a party and the two hit it off, talking about technology, coding and artificial intelligence. He claimed that even though they were at the party, Sushant "wasn't interested in drinking" and exressed his doubts about the actor consuming drugs. Read AlsoSushant Singh Rajput case: Subramanian Swamy claims'huge evidence' proves actor's death was'murder by conspiracy' He also claimed that the actor shared with him his ideas about developing artificial intelligence to benefit the poor people of the country.

Artificial intelligence and machine learning will play an even bigger role in healthcare in 2020 than they did in 2019, helping medical professionals with everything from oncology screenings to note-taking. On top of actual deployments, increased investment activity is also expected this year, and with deeper deployments of AI and ML technology, a broader base of test cases will be available to collect valuable best practices information. As AI is implemented more widely in real-world clinical practice, there will be more academic reports on the clinical benefits that have arisen from the real-world use, said Pete Durlach, senior vice president for healthcare strategy and new business development at Nuance. "With healthy clinical evidence, we'll see AI become more mainstream in various clinical settings, creating a positive feedback loop of more evidence-based research and use in the field," he explained. "Soon, it will be hard to imagine a doctor's visit, or a hospital stay that doesn't incorporate AI in numerous ways."

Investment in machine learning and artificial intelligence is ramping up across the healthcare industry as multiple players all look to tap into the benefits of deep neural networks and other forms of data-driven analysis. A number of forward-looking provider organizations made strides with AI in 2019, including Summa Health, a nonprofit health system in Northeast Ohio, and Sutter Health, a health system based in Sacramento, California, to name just two. Looking forward into 2020, administrative process improvements are expected to be an investment priority, including technologies to help automate business processes like administrative tasks or customer service. Many in the healthcare ecosystem already are on their way. An October Optum survey of 500 U.S. health industry leaders from hospitals, health plans, life sciences and employers, found 22% of respondents are in the late stages of AI strategy implementation.

The rapid uptake of mobile phones, cheaper and more Given the potentially large number of users of the Spoken widespread mobile connectivity, and increasing familiarity Web system and the likelihood of shared information needs with technology are driving Internet adoption in developing and significant user similarities, we expect considerable improvements nations, but major hurdles still remain. First, today's Internet in audio navigation from using CF. is mostly in English and is thus largely inaccessible to A useful distinction among CFbased approaches arises billions of people for whom English is not a native or second from the types of data used to associate users to products language. Second, today's Internet is accessible largely and other items. In some scenarios, users may provide explicit through text-based technologies (web browsing, email, text feedback about their interest in products through ratings.